mechlorethamine has been researched along with methoxsalen in 10 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 7 (70.00) | 18.7374 |
1990's | 2 (20.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (10.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Husby, G; Volden, G | 1 |
Basler, RS; Lynch, PJ | 1 |
Thomsen, K | 1 |
Fitzpatrick, TB; Gilchrest, BA; Haynes, HA; Parrish, JA; Tanenbaum, L | 1 |
Rees, RB | 1 |
Sasaki, MS; Tonomura, A | 1 |
Davies, RE; Forbes, PD; Urbach, F | 1 |
Chu, G; Payne, A | 1 |
Bunn, PA | 1 |
2 review(s) available for mechlorethamine and methoxsalen
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Modification of photocarcinogenesis by chemical agents.
Topics: Animals; Carcinogens; Dose-Response Relationship, Radiation; Mechlorethamine; Methoxsalen; Neoplasms; Photosensitivity Disorders; Time Factors; Ultraviolet Rays; Whole-Body Irradiation | 1982 |
8 other study(ies) available for mechlorethamine and methoxsalen
Article | Year |
---|---|
Occurrence of immunoglobulins and complement in the skin of patients undergoing topical treatment of mycosis fungoides.
Topics: Complement System Proteins; Fluorescent Antibody Technique; Humans; Immunoglobulin A; Immunoglobulin G; Immunoglobulin M; Immunoglobulins; Mechlorethamine; Methoxsalen; Mycosis Fungoides; Photochemotherapy; Skin; Skin Neoplasms | 1979 |
Mycosis fungoides: clinical and therapeutic review.
Topics: Humans; Lymphoma; Mechlorethamine; Methoxsalen; Mycosis Fungoides; Photochemotherapy; Sezary Syndrome; Skin Neoplasms | 1979 |
Scandinavian mycosis fungoides trial.
Topics: Administration, Topical; Antineoplastic Agents; Female; Humans; Male; Mechlorethamine; Methoxsalen; Mycosis Fungoides; Photochemotherapy; Remission, Spontaneous; Skin Neoplasms; Time Factors | 1979 |
Oral methoxsalen photochemotherapy of mycosis fungoides.
Topics: Administration, Oral; Aged; Female; Humans; Male; Mechlorethamine; Methoxsalen; Middle Aged; Mycosis Fungoides; Photochemistry; Radiotherapy, High-Energy; Skin Neoplasms; Ultraviolet Therapy | 1976 |
Psoriasis: clinical aspects and management.
Topics: Administration, Topical; Age Factors; Azauridine; Fluorouracil; Humans; Hydroxyurea; Mechlorethamine; Methotrexate; Methoxsalen; Nitrosourea Compounds; Psoriasis; Thiotepa; Triamcinolone Acetonide | 1976 |
A high susceptibility of Fanconi's anemia to chromosome breakage by DNA cross-linking agents.
Topics: Alkanesulfonates; Alkylating Agents; Anemia, Aplastic; Antimetabolites; Caffeine; Cell Division; Cells, Cultured; Chloramphenicol; Chromosome Aberrations; Chromosomes; Cobalt Isotopes; Dactinomycin; DNA Repair; Humans; Lymphocytes; Mechlorethamine; Methoxsalen; Mitomycins; Nitrosoguanidines; Quinolines; Radiation Effects; Ultraviolet Rays | 1973 |
Xeroderma pigmentosum group E binding factor recognizes a broad spectrum of DNA damage.
Topics: 4-Nitroquinoline-1-oxide; Cisplatin; DNA; DNA Damage; DNA Repair; DNA-Binding Proteins; Genetic Complementation Test; HeLa Cells; Humans; Mechlorethamine; Methoxsalen; Methylnitronitrosoguanidine; Mutagens; Ultraviolet Rays; Xeroderma Pigmentosum | 1994 |
Cutaneous T cell lymphomas.
Topics: Administration, Topical; Humans; Lymphoma, T-Cell, Cutaneous; Mechlorethamine; Methoxsalen; Randomized Controlled Trials as Topic; Skin Neoplasms; Ultraviolet Therapy | 1994 |